CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 46 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 4.42 and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,896,759 | +1.0% | 9,103,054 | -3.4% | 1.59% | -2.3% |
| Q2 2023 | $58,329,701 | +60.8% | 9,423,215 | 0.0% | 1.63% | +22.6% |
| Q1 2023 | $36,279,378 | +69.7% | 9,423,215 | +36.7% | 1.33% | +47.0% |
| Q4 2022 | $21,372,470 | -22.9% | 6,894,345 | 0.0% | 0.90% | -21.2% |
| Q3 2022 | $27,715,000 | -17.5% | 6,894,345 | 0.0% | 1.14% | -29.4% |
| Q2 2022 | $33,575,000 | +113.2% | 6,894,345 | +292.7% | 1.62% | +157.3% |
| Q1 2022 | $15,747,000 | +207.7% | 1,755,545 | +286.2% | 0.63% | +238.7% |
| Q4 2021 | $5,118,000 | +291.3% | 454,545 | +671.7% | 0.19% | +279.6% |
| Q2 2021 | $1,308,000 | – | 58,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |